title: Maintenance of neonatal rat B cells in glucose-depleted medium: a perifusion study.
abstract: Two groups of monolayer cultures of pancreatic cells from the neonatal rat were maintained in glucose-depleted TCM 199 medium, supplemented with 5.5 mmol galactose/l, with or without 0.1 mmol 2-deoxyglucose/l. Another group was kept in medium with 5.5 mmol galactose/l alone, following exposure for 2 days to a medium with 5.5 mmol galactose/l and 10 mumol iodoacetic acid/l to kill fibroblasts selectively. Each of these monolayers was cultured in a perifusion system for a total of 7 days so that phasic insulin secretion could be compared. On day 0, B cells responded in a monophasic fashion to acute challenge with 16.7 mmol glucose/l whereas, in the presence of 10 mumol forskolin/l and 1 mmol 3-isobutyl-1-methyl-xanthine/l, the same dose of glucose stimulated a biphasic response of approximately the same magnitude. At a concentration of 10 mmol/l, leucine and 2-ketoisocaproate both produced only minimal increase in the second phase of secretion above the basal level. No response to secretagogues was seen under culture conditions without 2-deoxyglucose. In contrast, addition of 2-deoxyglucose to the galactose-supplemented medium stimulated B cells to secrete insulin in a biphasic fashion in response to a single dose of glucose, and the stimulatory effects of leucine and 2-ketoisocaproate were also remarkably increased. Moreover, when exposed to a linear concentration gradient of glucose, leucine or 2-ketoisocaproate, these B cells responded to secretagogues in a dose-dependent fashion.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Clinical Pathology, Hyogo College of Medicine, Nishinomiya, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Wakabayashi
authors.forename: S
authors.initials: S
authors.lastname: Kagawa
authors.forename: K
authors.initials: K
authors.lastname: Nakao
authors.forename: A
authors.initials: A
authors.lastname: Matsuoka
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D002208:Caproates / Q000494:pharmacology; D002478:Cells, Cultured; D003470:Culture Media; D003837:Deoxy Sugars / Q000494:pharmacology*; D003847:Deoxyglucose / Q000494:pharmacology*; D005947:Glucose / Q000494:pharmacology; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007461:Iodoacetates / Q000494:pharmacology; D019807:Iodoacetic Acid; D007515:Islets of Langerhans / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism; D007651:Keto Acids / Q000494:pharmacology; D007930:Leucine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains
chemical_list: D002208:Caproates; D003470:Culture Media; D003837:Deoxy Sugars; D007328:Insulin; D007461:Iodoacetates; D007651:Keto Acids; C013082:alpha-ketoisocaproic acid; D003847:Deoxyglucose; D007930:Leucine; D005947:Glucose; D019807:Iodoacetic Acid